| [1] |
Kolykhalov AA, Agapov EV, Blight KJ, et al. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science, 1997, 277:570-574.
|
| [2] |
Lohmann V, Korner F, Koch J, et al. Replication of subgenomic hepati- tis C virus RNAs in a hepatoma cell line. Science, 1999, 285:110-113.
|
| [3] |
Lawitz E, Reau N, Hinestrosa F, et al. Efficacy of sofos- buvir, velpatasvir, and GS-9857 in patients with genotype 1 hepatitis C virus infection in an open-label, phase 2 trial. Gastroenterology, 2016, 151:893-901.
|
| [4] |
Gane EJ, Kowdley KV, Pound D, et al. Efficacy of sofosbuvir, velpatasvir, and GS-9857 in patients with hepatitis C virus genotype 2, 3, 4, or 6 infections in an open-label, phase 2 trial. Gastroenterology, 2016, 151:902-909.
|
| [5] |
Rean CP, Morissette P, Regan HK, et al. Assessment of the clinical cardiac drug-drug interaction associated with the combination of hepatitis C virus nucleotide inhibitors and amiodarone in guinea pigs and rhesus monkeys. Hepatology, 2016, 64:1430-1441.
|
